Advanced UV Adhesives for Medical Devices Unveiled by Hoenle

Introduction

Hoenle Adhesives has expanded its portfolio of medical device UV-curable adhesive solutions for high-throughput medical device assembly, with a focus on modern photoinitiator chemistry and biocompatibility screening. The new formulations are positioned as TPO-free, IBOA-free, and CMR-free options that support risk-reduced material choices while maintaining practical bond performance on common medical substrates.

Meta-style summary (for fast scanning): This article covers medical UV adhesive options that are TPO-free (no diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide), IBOA-free (no isobornyl acrylate), and CMR-free (no substances classified as carcinogenic, mutagenic, or toxic for reproduction), along with ISO 10993-based biocompatibility testing considerations and practical guidance for validated medical device assembly.

TL;DR: Hoenle’s updated portfolio targets safer photochemistry (including TPO-free photoinitiator systems), ISO 10993-tested adhesive screening, and manufacturability with UV/LED curing.

Regulatory frameworks, chemical compliance, and terminology

Medical adhesive selection typically sits at the intersection of chemical regulations and medical device requirements. In the EU, manufacturers commonly consider:

• REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) under ECHA guidance for substance restrictions and supply-chain communication.
• MDR 2017/745 (EU Medical Device Regulation) for device-level safety and performance expectations, including material-related risk management and clinical evaluation context (official text).
• ISO 13485 (quality management system for medical devices) as the common production environment framework for controlled processes, documentation, and validation (ISO overview).

Within this context, Hoenle highlights formulations designed without:

• TPO: diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide (a photoinitiator used in many UV systems).
• IBOA: isobornyl acrylate (a reactive monomer often discussed in wearable/skin-contact supply chains).
• CMR substances: materials classified as carcinogenic, mutagenic, or toxic for reproduction under EU CLP (Classification, Labelling and Packaging).

TL;DR: The portfolio is framed for EU-oriented compliance awareness (REACH + MDR), with clearer material declarations (TPO-free, IBOA-free, CMR-free) that support regulated documentation workflows.

Biocompatibility and ISO 10993 testing (and what it does & doesn’t prove)

Hoenle states that its new medical-grade UV bonding solutions are tested against ISO 10993 biocompatibility protocols commonly used in medical device approvals. For engineers and regulatory teams, it helps to be explicit about typical parts of ISO 10993 that are frequently used for adhesive screening, such as:

• ISO 10993-5: tests for in vitro cytotoxicity (cell toxicity screening).
• ISO 10993-10: tests for irritation and skin sensitization.
• ISO 10993-11: tests for systemic toxicity (acute/subacute/subchronic, depending on plan).

Important scope note: ISO 10993 results apply to the adhesive sample as tested (including the specific cure state and extraction conditions used). Final biocompatibility must still be verified at the finished device level (materials, geometry, surface area-to-volume ratio, sterilization, residues, and intended contact duration all matter). For the standard itself, see the ISO 10993-1 overview (evaluation and testing within a risk management process).

TL;DR: “ISO 10993-tested adhesives” supports early risk reduction, but device makers still must confirm biocompatibility on the final, sterilized device and intended use case.

Where medical UV-curable adhesives fit best (vs. alternative joining methods)

UV/LED-curable medical adhesives are often selected when manufacturers need fast cycle time, low heat input, and controlled cure initiation. They are especially attractive for transparent-to-opaque assemblies (when the light path is available) and for multi-component disposables.

Common alternatives—and when they may be preferable—include:

• Solvent bonding: useful for certain thermoplastics but introduces solvent handling, drying time, and potential extractables/residuals considerations.
• Heat staking: robust for mechanical retention of plastics but can distort thin walls and adds thermal stress.
• Ultrasonic welding: fast and strong for compatible plastics; requires joint-feature design, tooling, and can create particulates/flash if not optimized.

UV bonding is typically preferred when assemblies require minimal thermal load, clean aesthetics, and repeatable, metered curing—assuming the joint can be illuminated or a dual-cure strategy is used for shadowed regions.

TL;DR: UV adhesives shine for speed and low thermal stress, while welding/heat staking can be better when light access is limited or all-plastic joints are ideal.

Applications and substrate compatibility in medical device assembly

The portfolio targets a wide range of disposable and durable device assemblies, including:

• Cannulas and needle bonding
• Breathing circuits, respiratory sets, and connectors
• Catheters and flexible tubing interfaces
• Reservoirs and fluid-management components
• Heat exchangers and thermal-management modules
• Blood collection sets and lancet assemblies
• Diagnostic cartridges and point-of-care consumables

Typical substrates referenced include stainless steel, polycarbonate (PC), and polypropylene (PP). Note that bonding low-surface-energy (LSE) plastics such as PP often requires surface activation (see “Design-for-manufacture tips” below).

TL;DR: The adhesives are positioned for common medical assemblies spanning metals, PC, and challenging plastics like PP—especially where fast, controlled cure is needed.

Product groups at a glance (property and use-case comparison)

TL;DR: The lineup spans general medical UV adhesives plus wearable-oriented IBOA-free options; most are designed for common 365–405 nm curing ecosystems.

Typical engineering performance ranges (what engineers usually ask first)

Because exact properties vary by grade and substrate, engineers often start with “family-level” ranges to shortlist materials, then confirm on their specific joint design and cure conditions. For UV/LED-curable acrylate-based medical-grade adhesive families, typical ranges seen across the market (and often used as practical starting points) include:

• Viscosity (at 25 °C): ~50 to 50,000 mPa·s (cP), from wicking grades to thixotropic gap fillers.
• Lap shear strength (substrate-dependent): ~5 to 25 MPa on compatible plastics/metals; lower on LSE plastics unless treated/primed.
• Tensile strength (bulk, grade-dependent): ~10 to 60 MPa.
• Elongation at break: ~5% to 200% (from rigid structural to flexible formulations).
• Hardness: ~Shore A 40 to Shore D 85 (soft wearable-style adhesives through rigid structural grades).

These are not product-specific guarantees; they are intended as a practical engineering frame of reference. Always validate with the supplier’s technical data sheet and your own testing on the actual substrate lot, surface prep, and sterilization condition.

TL;DR: Expect wide tunability (from low-viscosity wicking to thixotropic gap fill; soft Shore A to rigid Shore D), but confirm performance on your exact substrates and cure window.

Performance notes on TPO-free, CMR-free formulations (with test-scope clarification)

Hoenle reports that moving to TPO-free photoinitiator systems and fully CMR-free compositions did not inherently require a bond-strength penalty in their internal development work. A highlighted example is Vitralit E-7041 T (TPO-free, CMR-free, and IBOA-free), reported to show:

• 100% higher bond strength on PP to stainless steel
• 9% higher bond strength on PC to PC

Test-condition scope note (credibility and validation): Those improvement figures are stated as results from internal Hoenle comparative testing. For maximum credibility in engineering change control, users should confirm the exact method and parameters (e.g., lap shear method such as ASTM D1002 or ISO 4587, overlap geometry, surface preparation, irradiance/dose, post-cure conditioning, and time-to-test). Treat the published deltas as directional until reproduced under your process conditions.

TL;DR: Hoenle reports no automatic performance trade-off with TPO-free/CMR-free reformulation, but you should reproduce results using your joint design, cure dose, and substrate prep.

UV/LED cure conditions: wavelengths, irradiance, and exposure time (practical ranges)

Cure conditions strongly influence extractables, conversion, and final mechanical properties. Most modern medical-grade UV bonding solutions are designed around common LED and mercury/metal-halide wavelength bands. Typical engineering ranges:

• Wavelength: 365 nm (UV-A) and LED peaks at 385/395/405 nm. Many LED-curable medical adhesives are optimized for 385–405 nm to match high-efficiency LEDs.
• Irradiance (intensity at the bondline): often ~100 to 2,000 mW/cm² depending on lamp type, working distance, and heat limits.
• Exposure time: often ~1 to 30 seconds for thin, well-illuminated bondlines; longer for filled/opaque joints or lower irradiance.

As a rule of thumb, for a bondline thickness of ~50–200 µm with good light access, process development typically targets a robust dose window (energy) rather than a single time value. If the joint includes shadowed regions (metal cannulas, opaque housings), consider design changes for light access, multiple-angle curing, or dual-cure options where applicable.

TL;DR: Most systems cure in the 365–405 nm range, often at 100–2,000 mW/cm² and 1–30 s for thin bondlines—provided the light can reach the adhesive.

Sterilization compatibility considerations (EtO, gamma, e-beam, autoclave)

Sterilization can change polymer networks and interfaces, so it should be treated as part of adhesive qualification—not an afterthought. Typical considerations for UV-curable medical adhesives include:

• EtO (ethylene oxide): generally compatible for many UV acrylate systems, but validate aeration and residual control at the device level.
• Gamma and e-beam (electron beam): can cause yellowing, embrittlement, or strength shifts depending on dose and formulation; test mechanical performance and appearance post-sterilization.
• Autoclave (steam): high heat and moisture can challenge some UV-cured networks and plastic substrates (hydrolysis, stress cracking); use only if the adhesive and substrates are rated/validated for those conditions.

Because sterilization interacts with substrate selection, geometry, and dose, confirm post-sterilization properties (shear/peel, leak, and aging) in your validation plan.

TL;DR: EtO is often the easiest path, radiation can alter color and toughness, and autoclave is the most demanding—validate after your exact sterilization cycle.

How to choose the right adhesive (selection checklist for medical devices)

To speed down-selection, engineers often evaluate these criteria early:

• Substrate combination: metal-to-plastic, plastic-to-plastic, LSE plastics (e.g., PP) vs higher-energy plastics (e.g., PC).
• Joint requirements: leak-tight seal vs structural retention; peel/flex vs rigid load.
• Exposure environment: water, lipids, disinfectants, drug contact, repeated cleaning, humidity aging.
• Sterilization method: EtO vs gamma/e-beam vs autoclave and the expected post-sterilization property retention.
• Process constraints: cure access, cycle time, allowable heat, and in-line verification (dose monitoring).
• Regulatory strategy: material declarations (TPO-free/IBOA-free/CMR-free), ISO 10993-tested adhesive data, and device-level testing plan.

TL;DR: Start with substrates + environment + sterilization + cure access; then refine based on mechanical needs and your regulatory/testing plan.

Design-for-manufacture tips (bondline, surface prep, and common pitfalls)

UV bonding can be highly repeatable when the joint is designed for light access and consistent adhesive geometry. Practical tips:

• Bondline thickness: commonly target ~50–200 µm for structural joints; thinner for capillary/wicking grades, thicker only if the product is designed for gap fill.
• Surface preparation:
  • Clean oils/mold release (validated cleaning method).
  • For LSE plastics (e.g., PP), consider plasma or corona treatment to increase surface energy and improve adhesion; verify treatment aging effects.
• Oxygen inhibition: free-radical acrylate cure can be inhibited at the surface; mitigate with higher dose, inerting, or formulation choice (as applicable).
• Shadowed areas: if UV cannot reach the adhesive due to opaque parts, metal features, or geometry, redesign for light piping, add secondary cure angles, or consider dual-cure strategies where available.
• Heat management: high irradiance can heat sensitive plastics; optimize distance, exposure time, and fixture heat sinking.

TL;DR: Control bondline thickness, treat/clean surfaces (especially PP), and engineer the joint so UV can actually reach the adhesive—shadowing is the most common failure mode.

UV/LED curing systems, measurement, and a validation-friendly process chain

Adhesive performance in production depends as much on curing control as on chemistry. Hoenle pairs adhesives with UV/LED curing options such as LED spot systems, flood arrays, and conveyor/chamber solutions for automated throughput.

At-a-glance process chain:

1. Adhesive selection (substrates, sterilization, mechanics, regulatory constraints)
2. UV/LED curing system selection (wavelength, irradiance, optics, fixturing)
3. UV measurement + process validation (dose window, monitoring, documentation)

For measurement, two key terms should be defined:

• Irradiance: light intensity at the part surface (e.g., mW/cm²).
• Dose (energy): irradiance integrated over time (e.g., mJ/cm²), often the more reliable control variable.

For general UV measurement and radiometry concepts, the NIST (National Institute of Standards and Technology) photometry/radiometry resources are a useful authoritative reference starting point.

TL;DR: Treat UV bonding as a system: adhesive + lamp/LED + measurement. Control dose and document the window to support consistent quality.

Portfolio update strategy (material stewardship with practical limits)

Hoenle describes an internal material stewardship approach (including an internal “avoid list”) to reduce reliance on substances likely to become problematic from a regulatory or toxicological perspective. In practice, that can help manufacturers reduce reformulation churn and support more stable bills of materials.

Limitation worth stating explicitly: “free-from” positioning and ISO 10993-tested adhesive screening do not eliminate the need for device-level verification—especially when changes occur in sterilization method, substrates, pigments, or manufacturing residues.

TL;DR: Proactive material choices can reduce long-term risk, but device-level validation (including sterilization and process residues) remains essential.

Meet Hoenle Adhesives at MD&M West

Engineers and manufacturing teams can discuss application-specific bonding and curing topics with Hoenle at MD&M West (Booth 4448), including LED-curable medical adhesives, curing equipment selection, and approaches to UV dose monitoring for process validation.

TL;DR: Use the event to review real parts, cure access constraints, and validation needs—not just adhesive datasheets.

Conclusion

Hoenle’s updated medical-grade UV bonding solution portfolio emphasizes TPO-free photoinitiator systems and material declarations (including CMR-free and, for wearables, IBOA-free options) alongside ISO 10993-oriented biocompatibility screening. For manufacturers, the key engineering takeaway is that adhesive success depends on a validated system: substrate prep, joint design, controlled curing (365–405 nm), and measurement of irradiance and dose.

TL;DR: These medical UV adhesives are positioned for modern compliance expectations and fast manufacturing—but the best results come from validating cure dose, sterilization effects, and device-level biocompatibility.

FAQ

Q: What wavelength should I use for a medical device UV-curable adhesive—365, 385, 395, or 405 nm?

A: Many LED-curable medical adhesives are designed around 385/395/405 nm LED peaks, while some systems also cure well at 365 nm. The right choice depends on the adhesive photoinitiator package, part transparency, and desired depth of cure. Validate by measuring UV dose at the bondline and confirming mechanical performance (e.g., lap shear/leak) at low and high ends of your dose window.

Q: What ISO 10993 tests are most relevant for ISO 10993-tested adhesives used in patient-contact devices?

A: Common screening elements include ISO 10993-5 (cytotoxicity), ISO 10993-10 (irritation/sensitization), and ISO 10993-11 (systemic toxicity), selected based on contact type and duration per ISO 10993-1. Results apply to the adhesive as tested; you still need device-level biocompatibility evaluation on the finished, sterilized device and manufacturing process.

Q: Are TPO-free, IBOA-free, CMR-free medical UV adhesives automatically safer for every device?

A: They can reduce certain chemical concerns in the supply chain, but “free-from” claims are not a substitute for risk management. Safety depends on the full device: cure completeness, extractables/leachables profile, sterilization effects, and intended use. Use the declarations as inputs to your MDR technical documentation and verify performance and biocompatibility at the device level.

Q: What are typical storage conditions and shelf life for UV-curable medical adhesives?

A: Many UV-curable adhesives are stored cool and protected from light (often in the 5–25 °C range, per product instructions) to minimize premature polymerization and viscosity drift. Shelf life is formulation-specific (commonly months rather than years). Always follow the product label/technical data sheet, track lot numbers, and avoid repeated warm-up/cool-down cycles if viscosity stability is critical.

Q: Can these adhesives run in automated dispensing equipment, and how does viscosity affect dispensing?

A: Yes—UV adhesives are frequently dispensed via time-pressure, piston, progressive cavity, or jet systems. Choose viscosity based on the feature size and tolerance needs: low viscosity supports wicking and micro-volume dispensing, while higher viscosity/thixotropic grades help prevent slump on vertical surfaces. For automated lines (e.g., IV components, dialysis-set connectors, point-of-care cartridges), validate dispense repeatability, tip wetting/strings, and cure shadowing created by dispense geometry.

Q: How do I validate a UV curing process for medical device assembly?

A: Establish a validated dose window by correlating measured irradiance/dose to bond quality metrics (mechanical strength, leak rate, visual cure, and aging/sterilization retention). Calibrate or verify UV radiometers on a defined schedule (often tied to internal quality procedures), monitor lamp/LED aging, and document critical parameters (distance, exposure time, fixture position, and part cleanliness). For shadowed joints, include worst-case builds and multi-angle cure steps in the validation plan.